ZA84856B - New pharmaceutical preparation - Google Patents

New pharmaceutical preparation

Info

Publication number
ZA84856B
ZA84856B ZA84856A ZA84856A ZA84856B ZA 84856 B ZA84856 B ZA 84856B ZA 84856 A ZA84856 A ZA 84856A ZA 84856 A ZA84856 A ZA 84856A ZA 84856 B ZA84856 B ZA 84856B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparation
new pharmaceutical
new
preparation
pharmaceutical
Prior art date
Application number
ZA84856A
Other languages
English (en)
Inventor
Erik Johannes Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of ZA84856B publication Critical patent/ZA84856B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA84856A 1983-02-11 1984-02-06 New pharmaceutical preparation ZA84856B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
ZA84856B true ZA84856B (en) 1984-09-26

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA84856A ZA84856B (en) 1983-02-11 1984-02-06 New pharmaceutical preparation

Country Status (15)

Country Link
US (1) US4600577A (nl)
JP (1) JPS59155312A (nl)
BE (1) BE898882A (nl)
DE (1) DE3404595A1 (nl)
DK (1) DK58983D0 (nl)
ES (1) ES8608490A1 (nl)
FR (1) FR2540727B1 (nl)
GB (1) GB2134785B (nl)
IE (1) IE56604B1 (nl)
IT (1) IT1196682B (nl)
NL (1) NL8400430A (nl)
NZ (1) NZ207010A (nl)
PH (1) PH21734A (nl)
SE (1) SE447871B (nl)
ZA (1) ZA84856B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0579260A1 (en) * 1987-07-07 1994-01-19 Beecham Group Plc Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
ATE380022T1 (de) * 2001-01-31 2007-12-15 Evonik Roehm Gmbh Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
CN102014638A (zh) 2007-10-12 2011-04-13 武田制药北美公司 与食物摄入无关的治疗胃肠病症的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
US4600577A (en) 1986-07-15
ES8608490A1 (es) 1986-06-16
ES529660A0 (es) 1986-06-16
IT8467131A0 (it) 1984-02-13
IE56604B1 (en) 1991-10-09
DK58983D0 (da) 1983-02-11
GB8403572D0 (en) 1984-03-14
NL8400430A (nl) 1984-09-03
SE447871B (sv) 1986-12-22
JPS59155312A (ja) 1984-09-04
PH21734A (en) 1988-02-10
IE840146L (en) 1984-08-11
SE8400723L (sv) 1984-08-12
SE8400723D0 (sv) 1984-02-10
DE3404595C2 (nl) 1993-04-29
NZ207010A (en) 1987-06-30
FR2540727A1 (fr) 1984-08-17
DE3404595A1 (de) 1984-08-16
GB2134785A (en) 1984-08-22
GB2134785B (en) 1986-07-02
JPH0451528B2 (nl) 1992-08-19
IT1196682B (it) 1988-11-25
FR2540727B1 (fr) 1987-01-23
BE898882A (fr) 1984-08-10

Similar Documents

Publication Publication Date Title
GB8414688D0 (en) Pharmaceutical preparation
GB8325529D0 (en) Medicinal forms
GR80293B (en) Pharmaceutical composition
ZA842348B (en) Pharmaceutical compounds
ZA84856B (en) New pharmaceutical preparation
GB8413576D0 (en) Pharmaceutical preparation
GB8306264D0 (en) Pharmaceutical preparations
GB8417154D0 (en) Pharmaceutical composition
DE3466389D1 (en) Novel pharmaceutical compounds and their preparation
GB8410363D0 (en) Pharmaceutical preparation
GB8419863D0 (en) Pharmaceutical preparations
GB8407735D0 (en) Pharmaceutical composition
GB8328713D0 (en) Pharmaceutical preparations
GB8329238D0 (en) Pharmaceutical preparations
GB8415453D0 (en) Pharmaceutical preparations
GB8407765D0 (en) Pharmaceutical compounds
GB8308414D0 (en) Pharmaceutical composition
ZA845785B (en) Pharmaceutical unit
GB8619101D0 (en) Pharmaceutical compounds
GB8320429D0 (en) Pharmaceutical preparation
GB8320438D0 (en) Pharmaceutical preparation
GB8321648D0 (en) Pharmaceutical use
GB8321649D0 (en) Pharmaceutical use
GB8321801D0 (en) Pharmaceutical use
GB8412342D0 (en) Pharmaceutical preparations